Novel nanofibrous membrane‐supporting stem cell sheets for plasmid delivery and cell activation to accelerate wound healing. Issue 1 (12th August 2021)

• Record Type: Journal Article
• Authors: Zhu, Yanxia; Liao, Yuqi; Zhang, Yuanyuan; Shekh, Mehdihasan I.; Zhang, Jianhao; You, Ziyang; Du, Bing; Lian, Cuihong; He, Qianjun
• Is Part Of: Bioengineering & translational medicine. Volume 7:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-12
• Subjects: cell sheet -- chitosan -- gelatin -- stem cell -- sustained release -- tissue engineering -- wound healing; Bioengineering -- Periodicals; Drug development -- Periodicals; Drugs -- Testing -- Periodicals; 660.6
• DOI: 10.1002/btm2.10244
• Languages: English
• ISSNs: 2380-6761

Abstract

Abstract: The integration of biomaterials with cells for high overall performances is vitally important in tissue engineering, as scaffold‐free cell sheet lacks enough mechanical performance and cell viability while cell‐free scaffold possesses limited biological functions. In this study, we propose a new strategy to strengthen cell sheets and enhance cell activity for accelerating wound healing based on a novel sandwich structure of cell sheet‐plasmid@membrane‐cell sheet (CpMC). Specifically, the CpMC contains two adipose‐derived stem cell (ADSC) sheets on outer surfaces and an electrospun gelatin/chitosan nanofibrous membrane (NFM) encapsulating vascular endothelial growth factor (VEGF) plasmids in between. The physicochemical properties of NFM including swelling, stiffness, strength, elasticity, and biodegradation can be tailored by simply adjusting the ratio between gelatin and chitosan to be 7:3 which is optimal for most effectively supporting ADSCs adhesion and proliferation. The swelling/biodegradation of NFM mediates the sustained release of encapsulated VEGF plasmids into adjacent ADSCs, and NFM assists VEGF plasmids to promote the differentiation of ADSCs into endothelial, epidermal, and fibroblast cells, in support of the neoangiogenesis and regeneration of cutaneous tissues within 2 weeks. The proposed membrane‐supporting cell sheet strategy provides a new route to tissue engineering, and the developed CpMC demonstrates a high potential for clinical translation.